Search

Your search keyword '"Reindl, Markus"' showing total 8 results
Start Over Author "Reindl, Markus" Journal annals of neurology
8 results on '"Reindl, Markus"'

2. Reply to “Investigating the immunopathogenic mechanisms underlying MOGAD ”

Author

Keller, Christian W., primary, Lopez, Joseph A., additional, Wendel, Eva‐Maria, additional, Ramanathan, Sudarshini, additional, Gross, Catharina C., additional, Klotz, Luisa, additional, Reindl, Markus, additional, Dale, Russell C., additional, Wiendl, Heinz, additional, Rostásy, Kevin, additional, Brilot, Fabienne, additional, and Lünemann, Jan D., additional

Published
2021
Full Text
View/download PDF

3. Complement Activation Is a Prominent Feature ofMOGAD

Author

Keller, Christian W., primary, Lopez, Joseph A., additional, Wendel, Eva‐Maria, additional, Ramanathan, Sudarshini, additional, Gross, Catharina C., additional, Klotz, Luisa, additional, Reindl, Markus, additional, Dale, Russell C., additional, Wiendl, Heinz, additional, Rostásy, Kevin, additional, Brilot, Fabienne, additional, and Lünemann, Jan D., additional

Published
2021
Full Text
View/download PDF

5. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis

Author

Titulaer, Maarten J., Höftberger, Romana, Iizuka, Takahiro, Leypoldt, Frank, McCracken, Lindsey, Cellucci, Tania, Benson, Leslie A., Shu, Huidy, Irioka, Takashi, Hirano, Makito, Singh, Gagandeep, Calvo, Alvaro Cobo, Kaida, Kenichi, Morales, Pamela S., Wirtz, Paul W., Yamamoto, Tomotaka, Reindl, Markus, Rosenfeld, Myrna R., Graus, Francesc, Saiz, Albert, and Dalmau, Josep

Published
2014
Full Text
View/download PDF

7. Reply to "Investigating the Immunopathogenic Mechanisms Underlying MOGAD".

Author

Keller, Christian W., Lopez, Joseph A., Wendel, Eva‐Maria, Ramanathan, Sudarshini, Gross, Catharina C., Klotz, Luisa, Reindl, Markus, Dale, Russell C., Wiendl, Heinz, Rostásy, Kevin, Brilot, Fabienne, and Lünemann, Jan D.

Subjects
MYASTHENIA gravis, NEUROMYELITIS optica, COMPLEMENT (Immunology)
Abstract

We agree that further studies in larger and immunotherapy-naïve cohorts of patients are clearly needed to better assess complement activation profiles in patients with NMOSD. These control groups included demographically matched and immunotherapy-naïve patients with relapse-onset multiple sclerosis, demographically matched and immunotherapy-naïve pediatric patients, demographically matched healthy controls, and an additional smaller group of patients with aquaporin 4 (AQP4)-immunoglobulin G (IgG)-seropositive neuromyelitis optica spectrum disorder (NMOSD). For the latter, we used samples available at our institution that were predominantly derived from patients after initiation of immunotherapy (3/13 patients were immunotherapy-naïve, 10/13 patients received rituximab or cyclophosphamide). [Extracted from the article]

Published
2022
Full Text
View/download PDF

8. Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

Author

Bradl, Monika, primary, Misu, Tatsuro, additional, Takahashi, Toshiyuki, additional, Watanabe, Mitsutoshi, additional, Mader, Simone, additional, Reindl, Markus, additional, Adzemovic, Milena, additional, Bauer, Jan, additional, Berger, Thomas, additional, Fujihara, Kazuo, additional, Itoyama, Yasuto, additional, and Lassmann, Hans, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results